Coronavirus Outbreak
View and Filter All Stories

Latest Stories

Merck Bets On a One-Shot Vaccine in Race With Its Faster Rivals

In the race for a Covid-19 vaccine, Merck & Co. looks slow. The drugmaker formally announced its plans just after Memorial Day, shortly before America’s death toll from the coronavirus passed 100,000. It says human trials of one of its shots will begin in mid-August, months behind the likes of AstraZeneca, Moderna, and Pfizer, whose vaccines have already begun large-scale testing. Pfizer has said it could approach regulators for an emergency use authorization as early as October. Merck told Congress last month that 2021 is the absolute earliest it expects to have a vaccine ready, and its top executives have cast doubt on the rosier predictions being made for other shots.

View More

Telehealth Is Booming During Covid. Is it Here to Stay?

Millions of Americans have taken advantage of telehealth during the coronavirus pandemic, so why has it taken so long for widespread adoption?

Up Next

Coronavirus Is Taking Its Toll On Big Law

Coronavirus and Force Majeure Clauses

Coronavirus and the Ballot Box

Coronavirus Is Changing the Way Lawyers Work

'Essential Workers' Are Fighting Back


Jeannie Baumann on Bloomberg Radio On Covid-19 Treatments

Shira Stein on CDC’s Covid-19 Survey with Bloomberg Radio